Corporate Governance

The Board of your Company is entrusted with the responsibility to safeguard good governance and functioning of the Company. The Board Members are professionals drawn from diverse areas with vast experience and knowledge in their respective fields. The Board Members enjoy uninterrupted freedom for expressing their views and ideas in respect of any item included in the agenda and matters related to the corporate affairs. They also have complete freedom to deliberate on other matters with the permission of the Chairman subject to statutory restrictions. Statutory compliance reports are placed periodically before the Board for their review at the Board meetings.

The Board of Directors of the Company being professionals from diverse fields bring with them a wide range of professionalism, skills, knowledge, expertise, experience and enables the Board to discharge its responsibilities and provide effective leadership to the business. The Non-Executive including the Independent Directors bring external and wider perception and independence in the decision making. The Board from time to time reviews for addition to the Board and Senior Management of the Company (whether for expansion or for replacement), thereby planning for orderly succession to the Board of Directors and Senior Management.

At the beginning of the year under review, your Company had eight Directors on the Board comprising of four Independent, one Non- Executive Non-Independent being a woman Director, one Nominee Director and two Promoters; of which one being Executive Director. During the year, the following changes took place in the Board of the Company:

(a) Mr. Prabhakar Dalal (DIN: 00544948), an Independent Director, resigned effective from August 31, 2018;

(b) Mrs. Sharada Sundaram (DIN: 07067040), a Nominee Director, resigned effective from September 27, 2018;

(c) Mr. Mukul Desai (DIN: 00015126), an Independent Director, resigned effective from December 11, 2018; and

(d) Mr. Dhaval Mehta (DIN: 07501194), an Additional Director, in the capacity of an Independent Director, joined the Board effective from March 8, 2019

As a result of the aforesaid changes, at the end of the year i.e. on March 31, 2019, your Board comprised of six Directors with three Independent, one Non-Executive Non-Independent being a woman Director and two Promoters; of which one being Executive Director.

From the above, it can be noted that the Board of your Company is structured in such a manner, so as to maintain an optimum combination of Independent and Non-Independent, as well as Executive and Non-Executive Director. The Chairman of the Board, being a Promoter, is a Non-Executive Director and hence half of the Board comprises of Independent Directors. There is no Nominee Director on the Board of the Company.

Subsequent to year-end, Ms. Tanvi Joshi (DIN: 07703593), Non-Executive Non-Independent Director, resigned from the Directorship of the Company effective from August 14, 2019.

The composition of the Board and category of Directors are given in the below table:

• As per the provisions of Section 152(6) of the Companies Act, 2013 and Articles of Association of the
  The company, at every Annual General Meeting (AGM), out of the two-third of the total number of
  Directors (excluding Independent Directors), one-third of such Directors are liable to retire by
  rotation. Accordingly, Mr. Manohar Bidaye (DIN: 00010699) is the Director retiring by rotation at the
  forthcoming Twenty Fourth Annual General Meeting of the Company.
  Mr. Manohar Bidaye (DIN: 00010699), is Non-Executive Director and eligible, has offered
  himself for re-appointment as a Director, liable to retire by rotation.
  On November 14, 2019, Mrs. Shanthi Chauhan (DIN: 08608338) was appointed as an Additional
  Director, in the capacity of an Independent Director, on Board of the Company on the
  recommendation of the Nomination and Remuneration Committee, as per Section 161 of the
  Annual Report 2019-20 | 36
  Companies Act, 2013, to hold the office till the date of the ensuing Annual General Meeting. It is
  proposed to appoint Mrs. Chauhan as an Independent Director not liable to retire by rotation, for a
  term up to November 13, 2021, subject to the approval of the Members.
  As required under Listing Regulations, a brief resume of both the Directors, seeking appointment /
  re-appointment respectively at the ensuing AGM, along with the list of other companies in which they
  hold directorships and memberships of the Committees of the Board are furnished hereunder:

  NAME OF THE DIRECTOR	Mr. Manohar Bidaye	Mrs. Shanthi Chauhan
  FATHER’S NAME	Late Shri Gopal Bidaye	Shri Krishnan Nagalla
  DATE OF BIRTH	November 11, 1963	June 16, 1971
  AGE	55 years	49 years
  DATE OF FIRST APPOINTMENT ON THE BOARD	December 1, 1994	November 14, 2019
  DIRECTORS IDENTIFICATION NUMBER	00010699	08608338
  NATIONALITY	Indian	Indian
  EXPERIENCE(INCLUDING EXPERTISE IN SPECIFIC FUNCTIONAL AREAS)	Over 30 year of experience in Corporate Planning, Corporate Law, Finance, Taxation and other related areas	Creator of the bespoke Jewellery brand ‘Sattviki’’, Mrs. Chauhan has carved a niche for herself in that sector. designed menus for famous FMCG brands which include teaching the crew how to manage corporate and consumer level orders.
  QUALIFICATION	M.Com, LL.B.(Gen.), Company Secretary	Diploma holder in Hotel Management
  TERMS AND CONDITIONS OF RE-APPOINTMENT	In terms of Section 152(6) of the Companies Act, 2013, Mr. Manohar Bidaye who was re-appointed as a Director at the Annual General Meeting held on September 24, 2018 is liable to retire by rotation at the Meeting.	As per the resolution at Item No. 3 of the Notice convening this Meeting read with explanatory statement thereto, Mrs. Shanthi Chauhan is proposed to be appointed as an Independent Director.
  REMUNERATION LAST DRAWN	Mr. Manohar Bidaye was entitled to monthly remuneration for rendering advisory services to the Company, as approved by the Shareholders and Central Government, upto March 31, 2017. However, during the year under review, Mr. Manohar Bidaye has willingly opted for non-receipt of sitting fees during the year under review.	N.A.
  REMUNERATION LAST DRAWN	Not Applicable However, during the year under review, Mr. Manohar Bidaye has willingly opted for non-receipt of sitting fees.	Not Applicable
  REMUNERATION PROPOSED TO BE PAID	No remuneration, except for sitting fees.	No remuneration, except for sitting fees.
  NUMBER OF DIRECTORSHIPS IN OTHER COMPANIES	11	Nil
  LIST OF OUTSIDE DIRECTORSHIPS HELD (INCLUDES PUBLIC, PRIVATE, FOREIGN COMPANIES, COMPANIES UNDER SECTION 8)	Zicom SaaS Private Limited Unisafe Fire Protection Specialists India Private Limited ASTM Skills Private Limited Baronet Properties & Investmenst Private Limited Coronet Properties & Investments Private Limited Progressive Equifin Private Limited Success Equifin Private Limited Chaitra Telenet Private Limited Unisafe Fire Protection Specialists LLC, Dubai Phoenix International WLL, Qatar Zicom Security Projects Pte. Ltd., Singapore	Not Applicable
  LIST OF OTHER COMMITTEES IN WHICH DIRECTOR IS MEMBER / CHAIRMAN (INCLUDES ALL CHAIRMANSHIPS / MEMBERSHIPS OF AUDIT COMMITTEE, STAKEHOLDERS’ RELATIONSHIP COMMITTEE AND NOMINATION AND REMUNERATION COMMITTEE OF ALL PUBLIC LIMITED COMPANIES)	Zicom SaaS Private Limited – Member of Audit Committee Zicom SaaS Private Limited – Member of Nomination and Remuneration Committee	Not Applicable
  NUMBER OF SHARES HELD IN THE COMPANY	Nil	Nil
  RELATIONSHIP WITH OTHER DIRECTORS / KEY MANAGERIAL PERSONNEL	Not related to any Director / Key Managerial Personnel	Not related to any Director / Key Managerial Personnel
  NUMBER OF BOARD MEETINGS ATTENDED DURING THE FINANCIAL YEAR (2017-18)	5	1

• Board Meetings held: During the year under review, the Board met on five occasions, i.e. on May 28, 2019; August 14, 2019; October 25, 2019; November 14, 2019, and February 12, 2020. The maximum gap between the two meetings was not more than one hundred and twenty days as stipulated under Regulation 17(2) of the Listing Regulations. The information as specified in Part A of Schedule II of the Listing Regulations has been placed before the Board from time to time
  for its consideration. The maximum gap between the two meetings was not more than one hundred and twenty days as stipulated under Regulation 17(2) of the Listing Regulations. The information as specified in Part A of Schedule II of the Listing Regulations has been placed before the Board from time to time
  for its consideration.
• Chairmanship / Membership: Pursuant to Regulation 26 of the Listing Regulations, all the Directors have confirmed to the Company that none of them is a member of more than ten committees, or is chairperson of more than five committees across all listed / unlisted public companies in which they are acting as Directors.
• Periodical review of Compliance Reports: Reports on compliance with all statutory laws applicable to the Company have been periodically placed before the Board for review.
• None of the Directors are related to each other in any way.

Attendance of Directors at Board Meetings, Audit Committee Meetings, last Annual General Meeting (AGM), and a number of other Directorships and Chairpersonship / Membership of Committees of each Director in various companies:

*The details of Category of Directorship, Directorship, and Memberships (including Chairmanships) are as on
the date of cessation.
Alternate directorship, directorship/committee membership in private companies, foreign
companies, companies under Section 8 of the Companies Act, 2013, is not included while
calculating directorships in the above table.
Chairpersonship / Membership of only the Audit Committee and Stakeholders’ Relationship
Committee of all public limited companies has been considered.
Also includes the committees in which a Director holds a position as a Chairperson.

The composition, quorum, powers, role, etc., of the Audit Committee, are in accordance with provisions of Section 177 of the Companies Act, 2013 and Regulation 18 of the Listing
Regulations. The Audit Committee acts as a link between the Auditors and the Board of Directors. The Audit Committee inter-alia keeps checks on the adequacy of the internal control
systems, financial disclosures, and statutory compliances. Composition: The Audit Committee comprises of three (3) Non-Executive Directors, all of them
being financially literate and having accounts and financial management knowledge. The Majority i.e. two-thirds of the Audit Committee Members are Independent. Mr. K. D. Hodavdekar, Chairman of the Audit Committee, is a Certified Associate of Indian Institute of Bankers and Holder of Masters Degree in Commerce and Bachelors Degree in Law from Mumbai University, is Veteran Banker with more than 33 years experience in varied areas in Banking, Finance, and Management. The Chief Financial Officer (CFO) and representatives of the Statutory Auditors and Internal Auditors remain present at the Meetings. The Company Secretary acts as Secretary to the Committee Meetings. The Audit Committee invites such of the executives, professionals, and other persons, as it deems necessary for its functioning. The Chairman of the Audit Committee was present at the 25th Annual General Meeting held on September 30, 2019. During the year under review, the Board of your Company, through Resolution dated August 14, 2019, appointed Mr. K. D. Hodavdekar, Independent Director, as Chairman of Audit Committee from even date.
The Members of the Audit Committee are as follows:

Objective: The Audit Committee is constituted by the Board with intent to assist the latter in its oversight of – (i) the quality and integrity of the accounting, auditing, and reporting practices of the Company; (ii) the integrity of the financial statements, the appointment, independence, performance and remuneration of the Statutory and Internal Auditors; (iii) the independent
auditor’s qualifications; (iv) the performance of the Company’s internal audit function and independent auditors; and (v) the compliance with the legal and regulatory requirements.

Meetings: During the year under review, the Audit Committee met four times on May 28, 2019; August 14, 2019; November 14, 2019; and February 12, 2020. The maximum time gap between the two meetings did not exceed a period of one hundred and twenty days. The quorum of the Audit Committee meeting is two Independent Members. A requisite quorum was present at all the Committee meetings held during the year. The attendance of Members at the Audit Committee meetings held during the year is given in the table under Para II (F) above.

Terms of Reference:

The terms of reference of the Audit Committee cover the following:
i. Oversight of the Company’s financial reporting process and the disclosure of its financial information to ensure that the financial statement is correct, sufficient and credible.
ii. Recommending to the Board, the appointment, re-appointment, terms of appointment and, if required, the replacement or removal of the Statutory Auditors and the fixation of audit fees.
iii. Approving payment to Statutory Auditors for any other services rendered by the Statutory Auditors.
iv. Reviewing, with the management, the annual financial statements, and Auditor’s Report thereon before submission to the Board for approval, with particular reference to:
a. matters required to be included in the Director’s Responsibility Statement forming part of the Board’s Report in terms of clause (c) of sub-section 3 of Section 134 of the
Companies Act, 2013;
b. changes, if any, in accounting policies and practices and reasons for the same;
c. major accounting entries involving estimates based on the exercise of judgment by the management;
d. significant adjustments made in the financial statements arising out of audit findings;
e. compliance with listing and other legal requirements relating to Financial Statements;
f. disclosure of any related party transactions;
g. modified opinion(s) in the Draft Audit Report.
v. Reviewing, with the Management, the quarterly financial statements before submission to the
Board for approval.
vi. Reviewing, with the Management, the statement of uses/application of funds raised through an issue (public issue, rights issue, preferential issue, etc.) the statement of funds utilized for purposes other than those stated in the offer document/prospectus/notice and the report submitted by the monitoring agency monitoring the utilization of proceeds of a public or
the rights issue, and making appropriate recommendations to the Board to take up steps in this
matter.
vii. Review and monitor the Auditor’s independence and performance, and effectiveness of the audit process.
viii. Approval or any subsequent modification of transactions of the Company with related parties.
ix. Scrutiny of inter-corporate loans and investments.
x. Valuation of undertakings or assets of the company, wherever it is necessary.
xi. Evaluation of internal financial controls and risk management systems.
xii. Reviewing, with the Management, the performance of Statutory and Internal Auditors, and
adequacy of the internal control systems.
xiii. Reviewing the adequacy of the internal audit function, if any, including the structure of the
internal audit department, staffing, and seniority of the official heading the department,
reporting structure coverage, and frequency of internal audit.
xiv. Discussion with Internal Auditors, any significant findings, and follow-up thereon.
xv. Reviewing the findings of any internal investigations by the Internal Auditors into matters
where there is suspected fraud or irregularity or a failure of internal control systems of material nature and reporting the matter to the Board.
xvi. Discussion with the Statutory Auditors before the audit commences, about the nature and
scope of audit as well as post-audit discussions to ascertain any area of concern.
xvii. To look into the reasons for substantial defaults in the payment to the depositors, debenture
holders, shareholders (in case of non-payment of declared dividends), and creditors.
xviii. To review the functioning of the Whistle Blower Mechanism.
xix. Approval of appointment of CFO (i.e., the whole-time Finance Director or any other person
heading the finance function or discharging that function) after assessing the qualifications,
experience, and background, etc. of the candidate.

The composition, quorum, powers, role, etc., of the Nomination and Remuneration Committee, are in accordance with provisions of Section 178 of the Companies Act, 2013 and Regulation 19 of the Listing Regulations.

Composition: The Members of the Nomination and Remuneration Committee are as follows:

Terms of Reference:

The Terms of Reference inter-alia includes the following:

1. To formulate the criteria for determining qualifications, positive attributes, and independence of a Director, and recommend to the Board a policy, relating to the remuneration for the
Directors, Key Managerial Personnel, and other employees.
2. To formulate the criteria for evaluation of Independent Directors and the Board.
3. To devise a policy on Board diversity.
4. To identify persons who are qualified to become Directors and who may be appointed in senior management in accordance with the criteria laid down and to recommend to the Board
their appointment and/or removal.
5. To carry out an evaluation of every Director’s performance.
6. To provide reports after completion of the evaluation process by Directors.
7. Whether to extend or continue the term of appointment of the independent director, on the basis of the report of performance evaluation of independent directors.
8. To administer, monitor, and formulate detailed terms and conditions of Employees’ Stock Option Scheme.
9. To recommend to the Board, all remuneration, in whatever form, payable to senior management.
10. To carry out any other function as is mandated by the Board from time to time and/or enforced by any statutory notification, amendment or modification, as may be applicable.
11. To perform such other functions as may be necessary or appropriate for the performance of its duties.

Meetings:During the year under review, the Committee met once on October 25, 2019. The necessary quorum was present for all the Meetings. The Chairman of the Committee was present at the 25th Annual General Meeting held on September 30, 2019. The attendance of each Member at the said Meeting is stated below:

Remuneration Policy:

The Nomination and Remuneration Committee recommends the remuneration, including the commission based on the Net Profits of the Company, for the Managing Director / Director / other Whole-Time Directors (as the case may be), for approval by the Board and Members. Prior approval of Members is obtained in case of remuneration to Non-Executive Directors, except for sitting fees to the extent permitted. The remuneration paid is determined keeping in view the industry benchmark, the relative performance of the Company to the industry performance and review of remuneration packages of managerial personnel of other organizations. Perquisites and retirement benefits are paid according to the Company policy as applicable to senior executives of the Company, subject to a prescribed statutory ceiling.

While formulating the remuneration policy, the Nomination and Remuneration Committee ensures that:

1. the level and composition of remuneration is reasonable and sufficient to attract, retain and motivate Directors of the quality required to run the Company successfully;
2. relationship of remuneration to performance is clear and meets appropriate performance benchmarks; and
3. remuneration to Directors, Key Managerial Personnel, and Senior Management involves a balance between fixed and incentive pay reflecting short and long-term performance objectives appropriate to the working of the Company and its goals.

Independent Non-Executive Directors are appointed for their professional expertise in their individual capacity as independent professionals/business executives. Non-Executive Directors are paid sitting fees for attending the meetings of the Board and various other Committees, which is determined keeping in view comparable industry and corporate standards.

The remuneration of employees largely consists of basic salary, perquisites, bonus, and performance incentives. The components of the total remuneration vary for different grades and are governed by the industry pattern, qualification & experience/merits, performance of each employee. The main objective of the remuneration policy is to motivate each and every employee and to stimulate excellence in their performance, recognize merits/achievements in order to retain the talent in the Company, and promote the feeling of belongingness.

In addition to the above, the Directors (other than Promoters and Independent Directors) and the employees may be granted stock options under the Employees Stock Options Scheme of the Company as may be approved by the Shareholders and decided by the Nomination and
Remuneration Committee of Directors from time to time.

Details of Remuneration to Directors:

Remuneration to other Non-Executive Directors

• Remuneration by way of sitting fees for attending Board and Committee meetings are paid to Non-Executive Directors (other than the Chairman). Sitting fees vary from type of meetings attended.
•  During the year, the Non-Executive Directors were paid sitting fees for attending each of the following meetings of the Company as under:

   

  TYPE OF MEETINGS	SITTING FEES (IN RS.)
  Board Meeting	15,000
  Audit Committee Meeting	5,000
  Stakeholders’ Relationship Committee Meeting	1,500
  Other Committees Meetings	2,500

• Details of sitting fees paid to Non-Executive Directors during the year are as under:

   

  	(Rs. Lakh)
  NAME OF NON-EXECUTIVE DIRECTORS	SITTING FEES
  Mr. K. D. Hodavdekar	1,00,500
  Mr. Anil Khanna	1,12,500
  Mr. Dhaval Mehta	60000
  Mrs. Shanthi Chauhan (appointed w.e.f. November 14, 2019)	30000
  Ms. Tanvi Joshi (resigned w.e.f. August 14, 2019)	0
  Total	3,03,000

   

• No Non-Executive Director has any material pecuniary relationship or transactions with the Company.
• Mr. Manohar Bidaye, Promoter, and Non-Executive Director do not hold any Equity Shares as an individual. However, Mr.Manohar Bidaye is Director / Shareholder in four private companies who are holding shares in the Company as per details given below:

   

  SR. NO.	NAME OF THE COMPANY	NO. OF SHARES HELD	% OF SHAREHOLDING
  1	Baronet Properties and Investments Private Limited	235,652	0.57
  2	Coronet Properties and Investments Private Limited	8,86,286	2.15
  3	Progressive Equifin Private Limited	5,264	0.01
  4	Success Equifin Private Limited	521	0.00

  Except for Mr. Manohar Bidaye, as aforesaid, no other Non-Executive Directors hold any Equity Shares of the Company.

• No Directors were granted any Stock Options during the year under review, and none of them hold any Stock Options of the Company.
• None of the Directors hold any convertible instruments in the Company.

Performance Evaluation

Pursuant to the provisions of the Companies Act, 2013 and Listing Regulations, the annual performance evaluation of the Board was carried out. The Board / Nomination and Remuneration Committee of Directors has laid down the criteria for evaluation of the performance of the Board, its Committees, and individual Directors. A structured questionnaire prepared covering various aspects of the Board’s functioning such as adequacy of the composition of the Board and its Committee, Board procedures, development, etc. was circulated to Directors for the purpose of evaluation. The Independent Directors at their meeting held on March 17, 2020, carried out the performance evaluation of the Board as a whole, its Committees, Chairman of the Company, and Non-Independent Directors. Subsequently, the Board at its meeting held on July 30, 2020, discussed and evaluated the performance of the Board, its Committees, and individual Directors.

The composition, role, etc., of the Stakeholders’ Relationship Committee, are in accordance with provisions of Section 178 of the Companies Act, 2013 and Regulation 20 of the Listing Regulations.

Composition: During the year under review, the Stakeholders’ Relationship Committee was reconstituted and comprised of the following Directors as detailed below:

During the year under review, with the resignation of Mr. Mukul Desai as an Independent Director effective December 11, 2018; he also ceased to be Member of the Committee effective even date. Further, during the year under review, the Board of your Company through Circular Resolution dated January 3, 2019, appointed Mr. K. D. Hodavdekar, Independent Director, as a Member of Stakeholders’ Relationship Committee from even date.

Terms of Reference: The terms of reference, inter alia, are as follows:

1. To approve or deal with applications for transfer, transmission, transposition, and mutation of share certificates including duplicate, split, renewal, sub-division, or consolidation of certificates and to deal with all related matters.
2. To look into and redress Shareholders/investors grievances relating to:
   1. Transfer of shares;
   2. Non-receipt of declared dividends;
   3. Non-receipt of annual reports;
   4. All such complaints directly concerning the Shareholders / investors as stakeholders of the Company; and
   5. Any such matters that may be considered necessary in relation to Shareholders and investors of the Company.
3. To review measures taken for effective exercise of voting rights by shareholders.
4. To oversee the performance of the Company’s Registrar and Transfer Agents.
5. To monitor implementation and compliance with the Company’s Code of Conduct for Prohibition of Insider Trading.
6. To review measures taken for effective exercise of voting rights by shareholders.
7. To review adherence to the service standards adopted by the Company in respect of various services being rendered by the Registrar & Share Transfer Agent.
8. To review the various measures and initiatives taken by the Company for reducing the quantum of unclaimed dividends and ensuring timely receipt of dividend warrants / annual reports / statutory notices by the shareholders of the Company.
9. To carry out any other function as is mandated by the Board from time to time and / or enforced by any statutory notification, amendment or modification as may be applicable.

Meetings:

The Stakeholders Relationship Committee generally meets once a month depending on the frequency of grievances/transfer / duplicate requests received from the Shareholders. In the financial year 2019-20, the Committee met 11 times. The attendance of each Member at the said Meetings is stated below:

The Chairman of the Committee was present at the last Annual General Meeting held on September 24, 2018.

Compliance Officer: Ms. Kunjan Trivedi, Company Secretary, is the Compliance Officer for complying with the requirements of SEBI Regulations and the Listing Regulations with the Stock Exchanges in India.

Investor Grievance Redressal: The Company addresses all complaints, suggestions, and grievances expeditiously and replies have normally been sent/issued within 7 days, except in case of dispute over facts or other impediments. During the year, the Company received one complaint from the shareholder which was resolved satisfactorily. As a result, there were no pending complaints as of March 31, 2020.

As during the year under review, no complaints were received; hence the requirement of giving details of unresolved complaints does not apply.

Pursuant to Section 135 of the Companies Act, 2013, the Corporate Social Responsibility (CSR) Committee was constituted. For the year under review, the provisions of Section 135 of Companies Act, 2013 read with the relevant Rules relating to Corporate Social Responsibility do not apply to the Company, as it does not fall under any of the criteria specified under them.

Preferential Issue Committee:

Composition:

Corporate Social Responsibility (CSR) Committee comprises of following three Directors:

Terms of Reference:

1. To formulate and recommend to the Board a Corporate Social Responsibility Policy which shall indicate the activities to be undertaken by the Company as specified in Schedule VII of the Companies Act 2013;
2. To recommend the amount of expenditure to be incurred on the CSR activities; and
3. To monitor the CSR Policy of the Company from time to time.

Meetings:

During the year under review, one meetings of CSR Committee was held on May 29, 2018. All the Members were present at the Meetings.

1. Preferential Issue Committee: The Preferential Issue Committee comprises of the following Directors: Mr. Manohar Bidaye, Chairman; Mr. Pramoud Rao, Mr. K.D. Hodavdekar, Members. The Committee did not meet during the year under review.
2. Managing Committee: The Managing Committee comprises of the following Directors:Mr. Manohar Bidaye, Chairman; Mr. Pramoud Rao, and Mr. K.D. Hodavdekar, Members.  The Committee did not meet during the year under review.